Product Information

BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET is a generic product labeled by AvPAK, priced at $0.4620 per EA under NDC 50268014415. Its NADAC has been published 458 times since Nov 15, 2017.

FDA first approved this application on Feb 22, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET

Buprenorphine and Naloxone
$0.4620per EA
DEA Schedule CIII

Strength

2; .5 mg/1; mg/1

Manufacturer

AvPAK

NDC

50268014415

Classification

Generic

Dosage Form

TABLET

Route

SUBLINGUAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA203136

FDA Approved

2/22/2013

TE Code

AB

On Market Since

12/8/2016

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist
Partial Opioid Agonists

Price Statistics

The NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has been published 458 times since Nov 15, 2017, and over the history we have for it it has declined 80.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4620 per EA
All-time high$2.6511 (Jan 10, 2018)
All-time low$0.3740 (Nov 20, 2024)
52-week high$0.5463
52-week low$0.4123
Median price$0.7445
Average price$0.9725
Largest weekly change+58.5% (Aug 21, 2024)
Weeks tracked458
Tracking sinceNov 15, 2017

Price History

1W

+9.6%

1M

+9.6%

3M

+7.1%

6M

-3.3%

1Y

-15.4%

3Y

-13.9%

5Y

-50.6%

All

-80.3%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET, manufactured by AvPAK, is $0.4620 per EA (NDC 50268014415), effective Aug 19, 2026.

How has the price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET changed over time?

Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has declined 80.3%. It has been tracked across 458 weekly CMS publications since Nov 15, 2017.

What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?

Since Nov 15, 2017, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET has ranged from a low of $0.3740 (Nov 20, 2024) to a high of $2.6511 (Jan 10, 2018), with a median of $0.7445 per EA.

Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET?

BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET (NDC 50268014415) is labeled by AvPAK, and CMS classifies it as a generic product.